Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
LivaNova Finishes Feasibility Trial Of Transcatheter Mitral Valve, Anticipates 2020 CE Mark
Aug 12 2018
•
By
Reed Miller
LivaNova Caisson Transcatheter Mitral Valve Replacement (TMVR) system • Source: LivaNova PLC
More from Clinical Trials
More from R&D